Literature DB >> 18192118

A diagnostic dilemma in stem cell transplantation for beta-thalassemia major: progressive loss of take or pure red cell aplasia?

Giuseppe Visani, Moira Lucesole, Giuliana Leopardi, Barbara Guiducci, Claudio Giardini, Alessandro Isidori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18192118     DOI： 10.1007/bf02984007

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  6 in total

1.  Rituximab for pure red cell aplasia after ABO-mismatched allogeneic peripheral blood progenitor cell transplantation.

Authors:  Federica Sorà; Silvia De Matteis; Nicola Piccirillo; Patrizia Chiusolo; Luca Laurenti; Rossana Putzulu; Giuseppe Leone; Simona Sica
Journal:  Transfusion       Date:  2005-04       Impact factor: 3.157

2.  Mixed chimerism after bone marrow transplantation in thalassemia.

Authors:  S Nesci; M Manna; G Lucarelli; P Tonucci; M Donati; O Buffi; F Agostinelli; M Andreani
Journal:  Ann N Y Acad Sci       Date:  1998-06-30       Impact factor: 5.691

3.  Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature.

Authors:  Kalyani Narra; Hossein Borghaei; Tahseen Al-Saleem; Martin Höglund; Mitchell R Smith
Journal:  Leuk Res       Date:  2005-07-25       Impact factor: 3.156

4.  Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

Authors:  R Stasi; A Pagano; E Stipa; S Amadori
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

5.  Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia.

Authors:  M Zecca; P De Stefano; B Nobili; F Locatelli
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

6.  Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.

Authors:  Grzegorz Helbig; Beata Stella-Holowiecka; Malgorzata Krawczyk-Kulis; Jerzy Wojnar; Miroslaw Markiewicz; Maria Wojciechowska-Sadus; Malgorzata Kopera; Tomasz Kruzel; Jacek Najda; Katarzyna Nowak; Jerzy Holowiecki
Journal:  Haematologica       Date:  2005-11       Impact factor: 9.941
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.